20930282|t|CSF levels of heart fatty acid binding protein are altered during early phases of Alzheimer's disease.
20930282|a|Heart fatty acid binding protein (HFABP) has been proposed as a putative marker for dementia disorders. To evaluate the value of this protein as an early marker of Alzheimer's disease (AD), we analyzed HFABP level and the classical biomarkers amyloid-beta (Abeta)1-42, total tau (t-tau), and phosphorylated tau (p-tau) in cerebrospinal fluid (CSF) of patients with mild cognitive impairment (MCI) followed up for four years (n=41), AD (n=32), and subjects with other neurological diseases without dementia (OND, n=25). HFABP levels were higher in AD patients and in MCI converting to AD (MCI-AD) with respect to OND and to cognitively stable MCI patients (MCI-MCI). The receiver operator characteristics analysis for HFABP alone showed a sensitivity of 87% and a specificity of 81% for AD versus OND (area under the curve, AUC=0.83); sensitivity and specificity were 46% and 94%, respectively, when comparing MCI-MCI versus MCI-AD. CSF HFABP levels showed a strong positive correlation with both t-tau and p-tau. Interestingly, the ratio between HFABP and Abeta1-42 improved the performance in distinguishing AD from OND (sensitivity: 90%; specificity 82%, AUC=0.89), and gave the best accuracy in discriminating MCI-AD from MCI-MCI (sensitivity: 80%; specificity 100%, AUC=0.90). Survival analysis by means of Kaplan-Meier curve showed a significantly higher proportion of MCI patients converting to AD in the group with higher values of HFABP/Abeta1-42 ratio (cut-off=0.7). A significant correlation between HFABP/Abeta1-42 ratio and MMSE annual decrease rate was also documented (p<0.0001). HFABP /Abeta1-42 ratio might be a useful predictor of conversion in MCI patients.
20930282	82	101	Alzheimer's disease	Disease	MESH:D000544
20930282	137	142	HFABP	Gene	2170
20930282	187	205	dementia disorders	Disease	MESH:D003704
20930282	267	286	Alzheimer's disease	Disease	MESH:D000544
20930282	288	290	AD	Disease	MESH:D000544
20930282	305	310	HFABP	Gene	2170
20930282	378	381	tau	Gene	4137
20930282	410	413	tau	Gene	4137
20930282	417	420	tau	Gene	4137
20930282	454	462	patients	Species	9606
20930282	468	493	mild cognitive impairment	Disease	MESH:D060825
20930282	495	498	MCI	Disease	MESH:D060825
20930282	535	537	AD	Disease	MESH:D000544
20930282	570	591	neurological diseases	Disease	MESH:D020271
20930282	600	608	dementia	Disease	MESH:D003704
20930282	610	613	OND	Disease	
20930282	622	627	HFABP	Gene	2170
20930282	650	652	AD	Disease	MESH:D000544
20930282	653	661	patients	Species	9606
20930282	669	672	MCI	Disease	MESH:D060825
20930282	687	689	AD	Disease	MESH:D000544
20930282	691	694	MCI	Disease	MESH:D060825
20930282	695	697	AD	Disease	MESH:D000544
20930282	715	718	OND	Disease	
20930282	745	748	MCI	Disease	MESH:D060825
20930282	749	757	patients	Species	9606
20930282	759	762	MCI	Disease	MESH:D060825
20930282	763	766	MCI	Disease	MESH:D060825
20930282	820	825	HFABP	Gene	2170
20930282	889	891	AD	Disease	MESH:D000544
20930282	899	902	OND	Disease	
20930282	1012	1015	MCI	Disease	MESH:D060825
20930282	1016	1019	MCI	Disease	MESH:D060825
20930282	1027	1030	MCI	Disease	MESH:D060825
20930282	1031	1033	AD	Disease	MESH:D000544
20930282	1039	1044	HFABP	Gene	2170
20930282	1110	1114	-tau	Gene	4137
20930282	1149	1154	HFABP	Gene	2170
20930282	1212	1214	AD	Disease	MESH:D000544
20930282	1220	1223	OND	Disease	
20930282	1316	1319	MCI	Disease	MESH:D060825
20930282	1320	1322	AD	Disease	MESH:D000544
20930282	1328	1331	MCI	Disease	MESH:D060825
20930282	1332	1335	MCI	Disease	MESH:D060825
20930282	1477	1480	MCI	Disease	MESH:D060825
20930282	1481	1489	patients	Species	9606
20930282	1504	1506	AD	Disease	MESH:D000544
20930282	1542	1547	HFABP	Gene	2170
20930282	1613	1618	HFABP	Gene	2170
20930282	1697	1702	HFABP	Gene	2170
20930282	1765	1768	MCI	Disease	MESH:D060825
20930282	1769	1777	patients	Species	9606
20930282	Association	MESH:D003704	2170
20930282	Positive_Correlation	2170	4137
20930282	Positive_Correlation	MESH:D000544	2170
20930282	Positive_Correlation	MESH:D060825	2170

